Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Jounce Therapeutics Inc banner
J

Jounce Therapeutics Inc
F:21J

Watchlist Manager
Jounce Therapeutics Inc
F:21J
Watchlist
Price: 1.71 EUR Market Closed
Market Cap: €89.2m
Write Note Create Alert Ask AI

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
What is Dividend Safety Rate?
Previous Payment
-
Today
Next Payment
-
Today
Feb 15, 2026
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-

Dividend Yield
Jounce Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Dividend Per Share
Jounce Therapeutics Inc

Over the past 5 years, dividends per share for 21J have decreased by 0%.
What is dividend per share?
Dividend Streak
Growth 3Y
Growth 5Y
Growth 10Y
Ex-Dividend Date Amount Period Declaration Date Record Date Payment Date
Load More

Payout Ratio
Jounce Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Payout Statistics, Past 5 Years
Min
Max
Current Payout
Min Payout
Max Payout
Average Payout
Median Payout

Peers Comparison
Dividends

Company Safety Rate Dividend Yield Dividend Per Share Growth 5Y Growth 10Y Payout Ratio

Shareholder Yield

Current shareholder yield for 21J is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
= Dividend Yield
+ Buyback Yield
+ Debt Paydown Yield
Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Company Total Yield Dividend Yield Buyback Yield Debt Paydown Yield

Buybacks

Buyback Yield
Jounce Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Company Buyback Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Debt Paydown

Debt Paydown Yield
Jounce Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Company Debt Paydown Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Price Appreciation

21J Price
Jounce Therapeutics Inc

1Y 3Y 5Y 10Y 15Y 20Y
Annual Price Range
1.71
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return -21.69%
Standard Deviation of Annual Returns
N/A
Max Drawdown -95%
Shares Statistics
Market Capitalization 88.4m EUR
Shares Outstanding 52 140 300
Percentage of Shares Shorted
N/A

21J Return Decomposition
Main factors of price return

Stock Splits

No Stock Splits Found

We don't have any information about 21J's stock splits.

See Also

Summary
21J intrinsic value, competitors valuation, and company profile.
DCF Valuation
21J stock valuation using Discount Cash Flow valuation method.
Relative Valuation
21J stock valuation using valuation multiples.
Wall Street Estimates
21J price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
21J stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 317,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.